Investment in Minnesota’s thriving medtech scene hit a 6-year high in 2014 and the state saw a significant jump in pharma/biotech investments, according to LifeScience Alley’s annual report.
Monteris Medical
Vascular Dynamics reports raising $10 million in funding round | Medtech funding for the week of November 10, 2014
Monteris Medical raises $30m Series B round for NeuroBlate robotic brain tumor laser
Monteris Medical said a pair of new backers joined a $30 million Series B round it plans to use to expand the commercial footprint of its NeuroBlate robotic brain tumor laser.
OrthoSensor lands another $13M, closing $48M Series B round | Funding Roundup
OrthoSensor said it added $13 million to its Series B round, taking the total for the round to $48 million as it looks to capitalize on regulatory nods for its Verasense knee replacement device in the U.S. and Europe.
Monteris wins U.S. and Canadian nods for its NeuroBlate tumor “cooker”
Monteris Medical won a regulatory nod in the U.S. and in Canada for its NeuroBlate MRI-guided tumor ablation device, the company said.
Monteris Medical closes $7.8M round for brain tumor laser
Monteris Medical closed a $7.8 million funding round it plans to use to commercialize its NeuroBlate neurosurgical ablation device for treating brain tumors.
The round, led by Business Development Bank of Canada, also included the SWMF Life Science Fund and several independent parties. Monteris drummed up $9 million last May, according to a press release.
Sign up to get our free newsletters delivered right to your inbox.
[sead]
St. Jude Medical’s largest backer boosts stake by 30% | Wall Street Beat
St. Jude Medical‘s (NYSE:STJ) largest investor boosted its stake by more than 30%, to some 27.2 million shares, or about 10% of the medical device maker.
CardioInsight chief Arless replaced by 2-man “office of the president” | Personnel Moves
Monteris Medical drums up $3.4 million for brain tumor laser treatment
Monteris Medical Inc. raised $3.4 million in an equity round for a device that enables minimally invasive laser surgery for brain tumors, according to a regulatory filing.
Monteris hopes to stretch the funding round to about $4.5 million, CEO Jim Duncan said. The 25-employee company has garnered $21 million in investment funding since its 1999 inception.